These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8957443)

  • 1. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell anti-apoptotic mechanisms in inflammatory myopathies.
    Vattemi G; Tonin P; Filosto M; Spagnolo M; Rizzuto N; Tomelleri G
    J Neuroimmunol; 2000 Nov; 111(1-2):146-51. PubMed ID: 11063832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in idiopathic inflammatory myopathies with partial invasion; a role for CD8+ cytotoxic T cells?
    Danielsson O; Häggqvist B; Gröntoft L; Öllinger K; Ernerudh J
    PLoS One; 2020; 15(9):e0239176. PubMed ID: 32936839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
    De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
    Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.
    Dorph C; Englund P; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2006 Dec; 65(12):1565-71. PubMed ID: 16831829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.
    Behrens L; Bender A; Johnson MA; Hohlfeld R
    Brain; 1997 Jun; 120 ( Pt 6)():929-38. PubMed ID: 9217678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC; Dalakas MC
    Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
    Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
    Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular immunology and genetics of inflammatory muscle diseases.
    Dalakas MC
    Arch Neurol; 1998 Dec; 55(12):1509-12. PubMed ID: 9865793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
    Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection.
    Schneider C; Dalakas MC; Toyka KV; Said G; Hartung HP; Gold R
    Arch Neurol; 1999 Jan; 56(1):79-83. PubMed ID: 9923764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features.
    Mantegazza R; Bernasconi P; Confalonieri P; Cornelio F
    J Neurol; 1997 May; 244(5):277-87. PubMed ID: 9178151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
    Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of apoptosis in myositis and in normal muscle cells.
    Nagaraju K; Casciola-Rosen L; Rosen A; Thompson C; Loeffler L; Parker T; Danning C; Rochon PJ; Gillespie J; Plotz P
    J Immunol; 2000 May; 164(10):5459-65. PubMed ID: 10799913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
    Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.